Minutes joined U.S. veterans with PTSD on a week-long psychedelic retreat in Mexico. Nearly a year later, most of the vets ...

Supporters of psychedelic therapy hoped that MDMA would make history as the first illegal psychedelic to win FDA approval, paving the way for similar drugs to enter the medical mainstream.

WASHINGTON — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for posttraumatic stress disorder (PTSD) puts the therapy's near-term future in doubt ...

In June 2024, an FDA advisory committee voted overwhelmingly against the idea that the relevant clinical trials had proved the efficacy of MDMA for the treatment of PTSD. Just as decisively ...

It is considered to be more pleasure-inducing than other amphetamines, and for this reason, it has been a popular party drug. Some researchers call MDMA an “empathogen” or a “feeling enhancer.” PTSD ...

In June 2024, an FDA advisory committee voted overwhelmingly against the idea that the relevant clinical trials had proved the efficacy of MDMA for the treatment of PTSD. Just as decisively ...

MDMA came close ... should approve the drug, citing high rates of suicide among veterans with the condition. “Despite billions of federal dollars spent on addressing PTSD and mental health ...

In February, the FDA accepted Lykos’ new drug application for midomafetamine capsules for the treatment of PTSD in combination ... trial participants’ history of MDMA use and the contribution ...